Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-negative chronic hepatitis B: Week 72 TDF data and week 24 adefovir dipivoxil switch data (study 102)

被引：20

作者：

Marcellin, P. ^{[2
]}

Jacobson, I. ^{[9
]}

Habersetzer, F. ^{[8
]}

Senturk, H. ^{[7
]}

Andreone, P. ^{[6
]}

Moyes, C. ^{[5
]}

Horban, A. ^{[4
]}

Teuber, G. ^{[3
]}

Sorbel, J. ^{[1
]}

Anderson, J. ^{[1
]}

Mondou, E. ^{[1
]}

Quinn, J. ^{[1
]}

Rousseau, F. ^{[1
]}

机构：

[1] Gilead Sci Inc, Durham, NC USA

[2] Univ Paris, Hosp Beaujon, Clichy, France

[3] Univ Frankfurt, Frankfurt, Germany

[4] Hosp Infect Dis, Warsaw, Poland

[5] Hepatitis Fdn New Zealand, Whakatane, New Zealand

[6] Univ Bologna, Bologna, Italy

[7] Istanbul Univ, Cerrahpasa Tip Fak, Hastanesi Ic Hastaliklari, Istanbul, Turkey

[8] Hosp Civil Strasbourg, Strasbourg, France

[9] Cornell Univ, Weill Med Coll, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1016/S0168-8278(08)60059-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S26 / S26

页数：1